ProPhase Labs(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRPH ProPhase Labs

Pre-Mkt 12-19 06:37:34 EST

0.1051

+0.0001

+0.10%

盘前0.1036

-0.0015-1.43%

06:27 EST

High0.1167	Low0.1026	Vol3.90M
Open0.1143	D1 Closing0.1050	Amplitude13.43%
Mkt Cap4.85M	Tradable Cap4.50M	Total Shares46.18M
T/O436.48K	T/O Rate9.11%	Tradable Shares42.85M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRPH","market":"US","secType":"STK","nameCN":"ProPhase Labs","latestPrice":0.1051,"timestamp":1766091600000,"preClose":0.105,"halted":0,"volume":3904756,"hourTrading":{"tag":"盘前","latestPrice":0.1036,"preClose":0.1051,"latestTime":"06:27 EST","volume":144233,"amount":15254.5436256,"timestamp":1766143639016},"delay":0,"floatShares":42845800,"shares":46179017,"eps":-1.164057,"marketStatus":"Pre-Mkt","change":0.0001,"latestTime":"12-19 06:37:34 EST","open":0.1143,"high":0.1167,"low":0.1026,"amount":436484.59804436,"amplitude":0.134286,"askPrice":0.1189,"askSize":100,"bidPrice":0.1036,"bidSize":1837,"shortable":3,"etf":0,"ttmEps":-1.164057,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766154600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.1051,"preHourTrading":{"tag":"盘前","latestPrice":0.1036,"preClose":0.1051,"latestTime":"06:27 EST","volume":144233,"amount":15254.5436256,"timestamp":1766143639016},"postHourTrading":{"tag":"盘后","latestPrice":0.1064,"preClose":0.1051,"latestTime":"19:53 EST","volume":262068,"amount":27516.991903,"timestamp":1766105581679},"volumeRatio":1.6466156370734695,"impliedVol":1.0139,"impliedVolPercentile":0.751},"requestUrl":"/m/hq/s/PRPH/tweets","defaultTab":"tweets","newsList":[{"id":"2592155434","title":"ABL Diagnostics and ProPhase Labs Sign Letter of Intent for Proposed Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2592155434","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592155434?lang=en_us&edition=fundamental","pubTime":"2025-12-19 15:00","pubTimestamp":1766127627,"startTime":"0","endTime":"0","summary":"ABL Diagnostics has informed the market that Advanced Biological Laboratories S.A. , its controlling shareholder, and ProPhase Labs, Inc. have signed a non-binding letter of intent for a proposed reverse merger. If completed, ABL S.A. would become the majority owner of the combined company. The proposal is currently at a preliminary stage and is subject to due diligence, negotiation of definitive agreements, regulatory approvals, and other customary conditions. Both parties are targeting a 60-90 day period to finalize agreements. If no agreement is reached, both companies will continue to operate independently.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news br","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL64d3TH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2592185735","title":"ProPhase Labs Amends Charter to Enact 1-for-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2592185735","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592185735?lang=en_us&edition=fundamental","pubTime":"2025-12-19 02:31","pubTimestamp":1766082678,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. has issued an amendment to its current report, announcing the filing of a Certificate of Amendment to its Certificate of Incorporation to effect a 1-for-10 reverse stock split of its common stock. The amendment became effective on December 2, 2025, following approval by stockholders and the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDLbnCLw8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2591688756","title":"Prophase Labs Inc - Reverse Stock Split Effective December 22, 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2591688756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591688756?lang=en_us&edition=fundamental","pubTime":"2025-12-13 00:45","pubTimestamp":1765557912,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nFWN3XI16A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2591291688","title":"ProPhase Labs Files Amendment for 1-for-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2591291688","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591291688?lang=en_us&edition=fundamental","pubTime":"2025-12-13 00:41","pubTimestamp":1765557701,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. has filed an amendment to its Certificate of Incorporation to implement a 1-for-10 reverse stock split of its common stock, effective December 2, 2025. The move is part of the company's reverse merger strategy as disclosed in its recent proxy statement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL4fXBjK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586903262","title":"ProPhase Labs Inc. Held Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586903262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586903262?lang=en_us&edition=fundamental","pubTime":"2025-11-27 03:16","pubTimestamp":1764184570,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. held a Special Meeting of Stockholders on November 24, 2025. Shareholders approved all proposals presented at the meeting, including the clarification that the company may acquire digital assets, the creation of a new class of digital treasury shares, the authorization for the potential issuance of digital tokens, and the authority to effect one or more reverse or forward stock splits. Approval was also granted for a conditional amendment to increase authorized common stock and for the potential adjournment of the special meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Ret","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDLbcdZSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2586522662","title":"Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2586522662","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586522662?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:00","pubTimestamp":1764162000,"startTime":"0","endTime":"0","summary":"UNIONDALE, NY, Nov.  26, 2025  (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. The exclusive event, hosted by R","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195111/0/en/Join-ProPhase-Labs-Exclusive-Live-Investor-Webinar-and-Q-A-Session-on-December-1.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586340462","title":"BRIEF-Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease","url":"https://stock-news.laohu8.com/highlight/detail?id=2586340462","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586340462?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:16","pubTimestamp":1764108964,"startTime":"0","endTime":"0","summary":"BRIEF-Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment LeaseNov 25  - Prophase Labs Inc PRPH.O:PROPHASE LABS- ON NOV 21, RECEIVED CONFIRMATION FROM AVTECH AGREEING TO CONTINUE ITS FORBEARANCE UNDER CO'S EXISTING EQUIPMENT LEASEPROPHASE LABS- UNDER AVTECH'S UPDATED PAYMENT SCHEDULE, CO TO MAKE WEEKLY PAYMENTS BEGINNING NOV 28, UNTIL OUTSTANDING PAST-DUE AMOUNTS ARE CURRENTPROPHASE LABS INC - REMAINS IN COMMUNICATION WITH AVTECH REGARDING THESE PAYMENTSSource text: [ID:n0001493152-25-024986]Further company coverage: PRPH.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10T5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586404503","title":"BRIEF-Prophase Labs - Aware That Civil Action Pending In The United States District Court For The Eastern District Of New York Has Been Unsealed","url":"https://stock-news.laohu8.com/highlight/detail?id=2586404503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586404503?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:15","pubTimestamp":1764108948,"startTime":"0","endTime":"0","summary":"BRIEF-Prophase Labs - Aware That Civil Action Pending In The United States District Court For The Eastern District Of New York Has Been UnsealedNov 25  - Prophase Labs Inc PRPH.O:PROPHASE LABS - AWARE THAT CIVIL ACTION PENDING IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF NEW YORK HAS BEEN UNSEALEDPROPHASE LABS INC - DENIES WRONGDOING, MAINTAINS THAT ITS LABORATORY AND DIAGNOSTIC OPERATIONS FOLLOW COMPLIANCE STANDARDS - SEC FILINGPROPHASE LABS INC - EXPECTS NO IMPACT ON OPERATIONS FROM UNSEALED MATTER - SEC FILINGPROPHASE LABS INC - TO VIGOROUSLY DEFEND MATTER ONCE FORMALLY SERVED - SEC FILINGSource text: [ID:n0001493152-25-024988]Further company coverage: PRPH.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2586401346","title":"Prophase Labs- Under Avtech's Updated Payment Schedule, Co to Make Weekly Payments Beginning Nov 28, Until Outstanding Past-Due Amounts Are Current","url":"https://stock-news.laohu8.com/highlight/detail?id=2586401346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586401346?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:35","pubTimestamp":1764106543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10T5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586401344","title":"Prophase Labs Inc - Remains in Communication With Avtech Regarding These Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2586401344","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586401344?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:35","pubTimestamp":1764106543,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10T5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586401890","title":"Prophase Labs - Aware That Civil Action Pending in the United States District Court for the Eastern District of New York Has Been Unsealed","url":"https://stock-news.laohu8.com/highlight/detail?id=2586401890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586401890?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:34","pubTimestamp":1764106484,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586363401","title":"Prophase Labs Inc - Denies Wrongdoing, Maintains That Its Laboratory and Diagnostic Operations Follow Compliance Standards - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586363401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586363401?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:34","pubTimestamp":1764106484,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10Y0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586357401","title":"Prophase Labs Inc - Expects No Impact on Operations From Unsealed Matter - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586357401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586357401?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:34","pubTimestamp":1764106484,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10Y0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2586018354","title":"ProPhase Labs Faces Unsealed False Claims Act Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2586018354","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586018354?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:31","pubTimestamp":1764106294,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. has disclosed that a previously sealed civil action under the False Claims Act, originally filed in 2023, has been unsealed by the United States District Court for the Eastern District of New York. The company stated it had no prior knowledge of the lawsuit until receiving notice of the unsealing on November 21, 2025. ProPhase Labs denies any wrongdoing and asserts that its laboratory and diagnostic operations adhere to strict regulatory and compliance standards. The company does not expect the litigation to impact its ongoing operations or services and intends to vigorously defend itself in the matter. All prior private disputes with the plaintiff were resolved and dismissed in 2024, and are separate from the current qui tam action.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL1TxYb9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2584901189","title":"ProPhase Labs Reports Q3 Loss Amid Strategic Shifts","url":"https://stock-news.laohu8.com/highlight/detail?id=2584901189","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584901189?lang=en_us&edition=fundamental","pubTime":"2025-11-20 11:53","pubTimestamp":1763610825,"startTime":"0","endTime":"0","summary":"Prophase Labs ( ($PRPH) ) has released its Q3 earnings. Here is a breakdown of the information Prophase Labs presented to its investors. ProPhase L...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prophase-labs-reports-q3-loss-amid-strategic-shifts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prophase-labs-reports-q3-loss-amid-strategic-shifts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2584420539","title":"BRIEF-Prophase Labs Reported Results For The Third Quarter Ended September 30, 2025, And Will Hold A Virtual Conference Call Today At 2Pm Et.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584420539","media":"Reuters","labels":["conferences","dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584420539?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:23","pubTimestamp":1763562193,"startTime":"0","endTime":"0","summary":"BRIEF-Prophase Labs Reported Results For The Third Quarter Ended September 30, 2025, And Will Hold A Virtual Conference Call Today At 2Pm Et.Prophase Labs Inc PRPH.O:PROPHASE LABS REPORTED RESULTS FOR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA7LP0CK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2584428849","title":"ProPhase Labs Reports Q3 2025 Results and Highlights Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2584428849","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584428849?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:01","pubTimestamp":1763560894,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. reported its financial results for the third quarter ended September 30, 2025. The company highlighted several value drivers, including the Crown Medical initiative, which has entered the settlement phase with a goal of collecting over $50 million in net accounts receivable. ProPhase also announced the next-phase commercialization of its BE-Smart Esophageal Cancer Test, following a landmark study published in the Official Journal of the American College of Gastroenterology. Additionally, the Nebula Genomics subsidiary is now profitable on a pro-forma basis. ProPhase indicated that these developments, along with multiple strategic and partnership inquiries, remain significantly undervalued by the market. The company emphasized the importance of shareholder voting on current proxy proposals to maintain NASDAQ compliance and advance strategic initiatives.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL1993Zy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2584941666","title":"Prophase Labs Inc - Bankruptcy Court Has Approved Prophase Labs Subsidiaries' Chapter 11 Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941666","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584941666?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:13","pubTimestamp":1763557987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA7LP0CK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"gpt_icon":0},{"id":"2584941507","title":"Prophase Labs Inc - in Discussions for Strategic Initiative to Realize Significant Underlying Value in Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584941507?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:13","pubTimestamp":1763557987,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA7LP0CK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"gpt_icon":0},{"id":"2584941491","title":"ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941491","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584941491?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:00","pubTimestamp":1763557200,"startTime":"0","endTime":"0","summary":"ProPhase Labs in discussions for strategic initiative to realize significant underlying value in the Company. Voting for Current Proxy Critically Important.Crown Medical Achieves Final Hurdle. Appoint","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190917/0/en/ProPhase-Labs-Reported-Results-for-the-Third-Quarter-Ended-September-30-2025-and-Will-Hold-a-Virtual-Conference-Call-Today-at-2pm-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4581","BK4007","BK4561","PRPH","BK4144","ET","BK4590"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prophaselabs.com","stockEarnings":[{"period":"1week","weight":-0.2362},{"period":"1month","weight":-0.5928},{"period":"3month","weight":-0.7288},{"period":"6month","weight":-0.6872},{"period":"1year","weight":-0.8488},{"period":"ytd","weight":-0.8612}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.645161,"avgChangeRate":0.035682},{"month":2,"riseRate":0.354839,"avgChangeRate":0.003376},{"month":3,"riseRate":0.387097,"avgChangeRate":0.047341},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.078325},{"month":5,"riseRate":0.5625,"avgChangeRate":0.054081},{"month":6,"riseRate":0.25,"avgChangeRate":-0.019901},{"month":7,"riseRate":0.46875,"avgChangeRate":0.056784},{"month":8,"riseRate":0.5625,"avgChangeRate":0.012218},{"month":9,"riseRate":0.375,"avgChangeRate":-0.000591},{"month":10,"riseRate":0.46875,"avgChangeRate":0.042465},{"month":11,"riseRate":0.625,"avgChangeRate":0.064978},{"month":12,"riseRate":0.3125,"avgChangeRate":-0.019205}],"exchange":"NASDAQ","name":"ProPhase Labs","nameEN":"ProPhase Labs"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProPhase Labs(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ProPhase Labs(PRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ProPhase Labs,PRPH,ProPhase Labs股票,ProPhase Labs股票老虎,ProPhase Labs股票老虎国际,ProPhase Labs行情,ProPhase Labs股票行情,ProPhase Labs股价,ProPhase Labs股市,ProPhase Labs股票价格,ProPhase Labs股票交易,ProPhase Labs股票购买,ProPhase Labs股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProPhase Labs(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ProPhase Labs(PRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction